Proliferative activity in primary ovarian carcinoid tumors

Gynecological Endocrinology

Volumn 17, Issue 1, 2003, Pages 1-6

  Resl, M ^a   Reslova T ^a   Krejci E ^b   Vagunda, V ^b   Nakatani, Y ^c   Miyagi, E ^c   Bedrna, J ^a   Richter, P ^a   Vorisek K ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Carcinoid; Cell proliferation; KI 67; Ovary; Topoisomerase II

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; OVARIAN CARCINOID; OVARY TUMOR; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 0344837391     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.17.1.1.6     Document Type: Article

References (25)

1. World Health Organization. Histological Typing of Lung and Pleural Tumors. Geneva: World Health Organization, 3rd edn, Springer, 1999:45-6
2. Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases. J Exp Clin Cancer Res 2000;19:271-80
3. Davis KP, Hartmann LK, Keeney GL, Shapiro H. Primary ovarian carcinoid tumors. Gynecol Oncol 1996;61:259-65
4. Banzo J, Abos MD, Prats E, et al. The scintigraphy of somatostatin receptors in the carcinoid tumor. Rev Esp Med Nucl 2001;20:11-18
5. Takemori M, Nishimura R, Sugimura K, et al. Ovarian strumal carcinoid with markedly high serum levels of tumor markers. Gynecol Oncol 1995;58:266-9
6. Virgolini I, Patri P, Novotny C, et al. Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy. Ann Oncol 2001;12(Suppl 2):41-5
7. Dikman SH, Toker C. Strumal carcinoid of the ovary with muscularization. Cancer 1971;27:925-30
8. Kurman RJ. Blaustein's Pathology of the Female Genital Tract, 4th edn. Springer, 1994:886-92
9. Portela-Gomez GM, Grimelius L, Jahansson H, et al. Chromogranin A in human neuroendocrine tumors. Am J Surg Patrol 2001;25:1261-7
10. Sidhu J, Sanchez RL. Prostatic acid phosphatase in strumal carcinoids of the ovary: an immunohistochemical study. Cancer 1993;72:1673-8
11. Shigeta H, Taga M, Kurogi K, et al. Ovarian strumal carcinoid with severe constipation: immunohistochemical and mRNA analyses of peptide YY. Hum Patrol 1999;30:242-6
12. Yaegashi N, Tsuiki A, Shimizu T, et al. Ovarian carcinoid with severe constipation due to peptide YY production. Gynecol Oncol 1995;56:302-6
13. Basham KL, Hajdu SI, Teichberg S, Menzin A. Adenocarcinoid tumor of the ovary diagnosed during pregnancy. A case report. J Reprod Med 2000;45:758-61
14. Rabczynski JK, Zabel M, Prudlak L, et al. Strumal carcinoid of ovary: a case report with immunohistochemical investigation. Clin Exp Obstet Gynecol 1999;26:112-4
15. Zheng W, Sung CJ, Hanna I, et al. Alpha and beta subunits of inhibin/activin as a sex cord-stromal differentiation markers. Int J Gynecol Pathol 1997;16:263-71
16. Young RH. New and unusual aspects of ovarian germ cell tumors. Am J Surg Pathol 1993;17:1210-24
17. Khadilkar UN, Pai RR, Lahiri R, Kumar P. Ovarian strumal carcinoid - report of a case that metastasized. Indian J Pathol Microbiol 2000;43:459-61
18. Mandai M, Konishi I, Tsuruta Y, et al. Kruckenberg tumor from an occult appendical adenocarcinoid: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol 2001;97:90-5
19. Klein EA, Rosen MH. Bilateral Kruckenberg tumors due to appendical mucinous carcinoid. Int J Gynecol Pathol 1996;15:85-8
20. Baker PM, Oliva E, Young RH, et al. Ovarian mucinous carcinoids including some with a carcinomatous component: a report of 17 cases. Am J Surg Pathol 2001;25:557-68
21. Barbareschi M, Frigo B, Mosca L, et al. Bronchial carcinoids with S-100 positive sustentacular cells: a comparative study with gastrointestinal carcinoids, pehochromocytomas and paragangliomas. Path Res Pract 1990;186:212-22
22. Ottaviani G, Lavezzi AM, De Ruberto F, et al. The prognostic value of cell proliferation in colorectal adenomas assessed with tritiated thymidine and anti-proliferating cell nuclear antigen. Cancer Detect Prev 1999;23:57-63
23. Paradiso A, Schittulli F, Cellamare G, et al. Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negative breast cancer. J Clin Oncol Res 2001;19:3929-37
24. Resl M, Simek J, Bukac J, et al. DNA topoisomerase II-alpha in pulmonary carcinoid tumors. Path Res Pract 2001;197:169-73
25. Rudolph P, Peters K, Lorenz D, et al. Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens. Hum Pathol 1998;29:1216-22